Brain Cancer

OKN-007 is being evaluated both alone and in combination with chemotherapy for patients with glioma or glioblastoma — both types of brain cancer.

From composer Ryuichi Sakamoto’s death to the “King of Chemo” cycling across the United States to raise funds for mental health and cancer charities, here’s what’s happening in the oncology space this week.

From Robin Roberts providing an update on her partner, Amber Laign’s “rough year” with breast cancer, to Kathy Griffin’s suspected cause of lung cancer, here’s what’s happening in the oncology space this week.

This approval is the first of its kind as a first-line systemic therapy for pediatric patients with low-grade gliomas of a specific mutation.

From a contestant on “Queer Eye” dying of cancer to a string of brain cancers in former Philadelphia Phillies players, here’s what’s happening in the oncology space this week.

Experts are concerned that the train derailment in Ohio may pose cancer risks down the line.

Patients who are financially struggling due to job loss after a cancer diagnosis may benefit from multidisciplinary back-to-work programs and financial counseling, according to an expert.

The treatment previously demonstrated significantly improved overall survival for patients with recurrent glioblastoma in a phase 1 study.

Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study findings showed.

From investigative journalist, Drew Griffin’s cancer-related death to Jane Fonda’s lymphoma update, here’s what’s happening in the oncology space this week.

Robert Atteberry never gave up, even after three cancer diagnoses, and has found a motivation and passion for competing in triathlons during survivorship.

From Toby Keith providing fans with an update since his stomach cancer diagnosis to Katie Couric donating $25,000 worth of baby formula to moms with breast cancer, here’s what’s happening in the cancer space this week.

The first patient was enrolled in a phase 1 trial analyzing MTX110 in patients with recurrent glioblastoma, an aggressive type of brain cancer.

From a childhood cancer survivor throwing out the first pitch at Game 4 of the World Series to former WWE champion and actor Dwayne “The Rock” Johnson recording a message for a child with brain cancer, here’s what’s happening in the cancer space this week.

Receiving a brain cancer diagnosis was scary, but it taught me to be more forgiving to others and proud of what I have accomplished.

Ten years after my brain cancer diagnosis, I feel hopeful and content with my life.

From “Chicago Med” actress Marlyne Barrett announcing her gynecologic cancer diagnosis to a New York City-based news team walking in honor of their former news director who died of glioblastoma, a form of brain and spinal cord cancer, here’s what’s happening in the cancer space this week.

From the delay of some health care services in the United Kingdom due to Queen Elizabeth II’s funeral to actor Ryan Reynolds broadcasting his colonoscopy — including the finding of a pre-cancerous polyp — here’s what’s happening in the cancer space this week.

After being a 20-year brain tumor survivor, I met with a genetic counselor and learned that I have a MUYTH gene mutation.

The safety, optimal dosage and efficacy of the investigational drug is currently being evaluated in a first-in-human trial in patients with recurrent high-grade glioblastoma, a type of spinal cord and brain cancer.

The drug, known as BDTX-1535, is being investigated in patients with glioblastoma that harbors EGFR alterations and non-small cell lung cancer that harbors EGFR mutations of intrinsic or acquired resistance and disease that has failed standard treatment.

The plan to launch the phase 1 trial to evaluate the safety and efficacy of combining the CAR-T cell therapy and oncolytic virus in patients with recurrent glioblastoma, a type of brain cancer, is supported by interim data from two ongoing trials.

The study authors plan to enroll 24 patients with glioblastoma, an aggressive brain tumor, to assess the efficacy an investigational drug plus Libtayo prior to surgery to remove the tumor.

A phase 2b clinical trial evaluating the efficacy and safety of an immunotherapy drug for patients with brain cancer has opened at Roswell Park Comprehensive Cancer Center in Buffalo, New York, with additional plans to be carried out at more than a dozen sites.

A brain cancer survivor explains how she found a way to navigate her cancer journey as a traveler, grateful to be alive.

A brain tumor survivor explains how she chooses to approach life with acceptance of the hard times rather than trying to throw them away.

Patients with a common brain tumor subtype that expresses ERK1/2 activation may obtain a greater survival benefit with PD-1 immunotherapy, although research needs to confirm whether this can be observed in all patients.

From celebrity deaths to exciting new treatments, here is CURE®’s roundup of what made waves in the brain cancer space this year.

Upon recognizing the 50th anniversary of the National Cancer Act of 1971, President Joe Biden set forth his proposal for the Advanced Research Projects Agency for Health.

From the deaths of Jovita Moore and Jerry Remy due to cancer, to Boyd Huppert’s myeloma diagnosis, here’s what’s happening in the cancer landscape this week.